BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19094586)

  • 1. [Relationship between expression of caveolin-1 and pERK1/2 and prognosis in non-small cell lung cancer].
    Liu HX; Xing LX; Wang HB; Yang JQ; Sun YM
    Zhonghua Bing Li Xue Za Zhi; 2008 Sep; 37(9):615-9. PubMed ID: 19094586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on expression and methylation of caveolin 1 gene in non-small cell lung cancers].
    Zhang YX; Chen HL; Ye B; Yang F; Yu LY
    Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):300-4. PubMed ID: 18956646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of caveolin-1 expression in primary lung cancer].
    Yu JH; Wei Q; Qi FJ; Xu HT; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2006 Nov; 35(11):664-8. PubMed ID: 17374210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression and function of the caveolin-1 gene in non-small cell lung carcinoma.
    Chen HL; Fan LF; Gao J; Ouyang JP; Zhang YX
    Oncol Rep; 2011 Feb; 25(2):359-66. PubMed ID: 21165568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma].
    Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
    Zheng S; Chang Y; Hodges KB; Sun Y; Ma X; Xue Y; Williamson SR; Lopez-Beltran A; Montironi R; Cheng L
    Anticancer Res; 2010 Mar; 30(3):713-8. PubMed ID: 20392988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and predictive values of pERK1/2 and pAkt-1 expression in non-small cell lung cancer patients treated with adjuvant chemotherapy.
    Shi Y; Chen L; Li J; Lv YL; Sun Q; Wang LX; Jiao SC
    Tumour Biol; 2011 Apr; 32(2):381-90. PubMed ID: 21086091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
    Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
    Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
    Miao LJ; Wang J; Li SS; Wu YM; Wu YJ; Wang XC
    Ai Zheng; 2006 Oct; 25(10):1216-20. PubMed ID: 17059763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of cytoplasmic PLZF correlates with high tumor grade and tumor aggression in non-small cell lung carcinoma.
    Xiao GQ; Li F; Findeis-Hosey J; Hyrien O; Unger PD; Xiao L; Dunne R; Kim ES; Yang Q; McMahon L; Burstein DE
    Hum Pathol; 2015 Nov; 46(11):1607-15. PubMed ID: 26297253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells.
    Yin Z; Zhang Y; Li Y; Lv T; Liu J; Wang X
    Acta Histochem; 2012 Feb; 114(2):151-8. PubMed ID: 21549414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Association of HAb18G with clinicopathologic features and prognosis in non-small cell carcinoma of lung].
    Xu XY; Zhi C; Li YM; Qi WJ; Mei JJ; Yan ZM; Shen H
    Zhonghua Bing Li Xue Za Zhi; 2012 Mar; 41(3):151-5. PubMed ID: 22800476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gene diagnosis and prognosis of mediastinal lymph node occult micrometastasis in non-small cell lung carcinoma].
    Wang Z; Yin H; Zhang L; Lan X; Li H
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):247-9. PubMed ID: 12515617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of CD88 predicts poor prognosis in non-small-cell lung cancer.
    Gu J; Ding JY; Lu CL; Lin ZW; Chu YW; Zhao GY; Guo J; Ge D
    Lung Cancer; 2013 Aug; 81(2):259-65. PubMed ID: 23706417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expressions of Axin and beta-catenin in non-small cell lung cancer].
    Xu HT; Wang L; Lin D; Liu Y; Liu N; Wang EH
    Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):519-23. PubMed ID: 16383300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours.
    Vicent S; López-Picazo JM; Toledo G; Lozano MD; Torre W; Garcia-Corchón C; Quero C; Soria JC; Martín-Algarra S; Manzano RG; Montuenga LM
    Br J Cancer; 2004 Mar; 90(5):1047-52. PubMed ID: 14997206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of Smac in Stage I-II non-small cell lung cancer and its clinical significance].
    Zhao JM; Zhu ZH; Wu QL; Hou JH; Huang XP; Zhang PY; Rong TH
    Ai Zheng; 2006 May; 25(5):631-4. PubMed ID: 16687088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.